The effect of pentoxifylline on the healing of intestinal anastomosis in rats with experimental obstructive jaundice

Surgery Today

Volumn 30, Issue 10, 2000, Pages 896-902

  Cömert, Mustafa ^a   Taneri, Ferit ^a   Tekin, Ercüment ^a   Ersoy, Emin ^a   Öktemer, Selçuk ^a   Onuk, Erhan ^a   Düzgün, Ersel ^a   Ayoǧlu, Ferruh ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Endotoxemia; Intestinal anastomosis; Obstructive jaundice; Pentoxifylline; Tumor necrosis factor

Indexed keywords

ANESTHETIC AGENT; ENDOTOXIN; KETAMINE; PENTOXIFYLLINE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANASTOMOSIS; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; IMMUNE RESPONSE; INTESTINE ANASTOMOSIS; INTESTINE SURGERY; JAUNDICE; MOUSE; NONHUMAN; OBSTRUCTIVE JAUNDICE; POSTOPERATIVE PERIOD; WOUND HEALING;

EID: 0033765677     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950070041     Document Type: Article

References (59)

1. Acute postoperative renal failure in obstructive jaundice
2. Surgical aspects of jaundice
3. Perioperative complications in obstructive jaundice: Therapeutic considerations
4. Renal failure complicating obstructive jaundice
5. Surgical experience of deeply jaundiced patients with bile duct obstruction
6. Factors affecting morbidity and mortality after surgery for obstructive jaundice: A review of 373 patients
7. Prediction of risk in biliary surgery
8. Abdominal wound healing in jaundiced patients
9. Wound healing in obstructive jaundice
10. Jaundice and wound healing; an experimental study
11. Effect of obstructive jaundice on wound healing
12. Jaundice and the effect of sodium taurocholate taken orally upon abdominal wound healing
13. The effect of obstructive jaundice on the migration of reticulo-endothelial cells and fibroblasts into early experimental granulomata
14. Measurement of operative plasma endotoxin levels in jaundiced and non-jaundiced patients
15. Complications in obstructive jaundice: Role of endotoxins
16. Endotoxin, bile salts and renal function in obstructive jaundice
17. Study of reticuloendothelial phagocytic capacity in patients with cholestasis
18. Lactulose - A drug with antiendotoxin effect
19. The effect of preoperative bile salt administration on postoperative renal function in patients with obstructive jaundice
20. Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin
21. Macrophages as a source tumoricidal activity (tumor necrosis factor)
22. Shock and tissue injury induced by recombinant human cachectin
23. Cachectin: More than a tumor necrosis factor
24. Wound healing
25. General principles of wound healing
26. Healing in the gastrointestinal tract
27. The effect of oral sodium taurocholate on endotoxemia and intestinal anastomotic wound healing in rats with obstructive jaundice
28. A simple method to determine nanogram levels of 4 hydroxyproline in biological tissues
29. Healing of experimental intestinal anastomoses: Parameters for repair
30. The effect of acute haemorrhage and of delayed blood replacement on wound healing: An experimental study
31. Studies on the biology of collagen during wound healing
32. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice
33. Bile salts, endotoxin and renal function in obstructive jaundice
34. Cachectin/tumor necrosis factor; production, distribution, and metabolic fate in vivo
35. Detection of circulating tumor necrosis factor after endotoxin administration
36. Stimulation of the adherence of neutrophils to umblical vein endothelium by human recombinant tumor necrosis factor
37. Tumor necrosis factor provokes superoxide anion generation from neutrophils
38. Stimulation of neutrophils by tumor necrosis factor
39. Tumor necrosis factor α inhibits collagen gene transcription and collagene synthesis in cultured human fibroblasts
40. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1
41. 2-stimulating activity in rheumatoid synovial cells
42. 2 production by human synovial cells and fibroblasts
43. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1
44. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
45. Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo
46. Characterization of wound cytokines in the sponge matrix model
47. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice
48. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin induced raw 264.7 cells
49. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion
50. Prevention of postoperative complications in jaundiced rats
51. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline
52. Differential effect of oxpentifylline on tumor necrosis factor and interleukin-6 production
53. Pentoxifylline increases survival in murine endotoxin shock and decreases TNF formation
54. Oxpentifylline in endotoxaemia
55. ARDS, neutrophils, and pentoxifylline
56. Effect of pentoxifylline on the phagocytotic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells
57. Inhibition of the inflammatory action of interleukin 1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline
58. The effect of pentoxifylline in septic shock - New pharmachologic aspects of an established drug
59. Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog